Literature DB >> 35344616

Phenotypic and mutational spectrum of ROR2-related Robinow syndrome.

Ariadne R Lima1, Barbara M Ferreira2, Chaofan Zhang3, Angad Jolly3,4, Haowei Du3, Janson J White5, Moez Dawood3,4,6, Tulio C Lins7, Marcela A Chiabai7, Ellen van Beusekom8, Mara S Cordoba9,10, Erica C C Caldas Rosa1, Hulya Kayserili11, Virginia Kimonis12, Erica Wu13, Cecilia Mellado14, Vineet Aggarwal15, Antonio Richieri-Costa16, Décio Brunoni17, Talyta M Canó2,18, Alexander A L Jorge19, Chong A Kim20, Rachel Honjo20, Débora R Bertola20,21, Raissa M Dandalo-Girardi22, Yavuz Bayram23,24, Alper Gezdirici25, Elif Yilmaz-Gulec26, Evren Gumus27, Gülay C Yilmaz27, Nobuhiko Okamoto28, Hirofumi Ohashi29, Zeynep Coban-Akdemir3,30, Tadahiro Mitani3, Shalini N Jhangiani6, Donna M Muzny6, Neysa A P Regattieri9, Robert Pogue7, Rinaldo W Pereira7, Paulo A Otto21, Richard A Gibbs6, Bassam R Ali31, Hans van Bokhoven8, Han G Brunner8, V Reid Sutton3,32, James R Lupski3,6,32,33, Angela M Vianna-Morgante21, Claudia M B Carvalho3,34, Juliana F Mazzeu1,2,9,35.   

Abstract

Robinow syndrome is characterized by a triad of craniofacial dysmorphisms, disproportionate-limb short stature, and genital hypoplasia. A significant degree of phenotypic variability seems to correlate with different genes/loci. Disturbances of the noncanonical WNT-pathway have been identified as the main cause of the syndrome. Biallelic variants in ROR2 cause an autosomal recessive form of the syndrome with distinctive skeletal findings. Twenty-two patients with a clinical diagnosis of autosomal recessive Robinow syndrome were screened for variants in ROR2 using multiple molecular approaches. We identified 25 putatively pathogenic ROR2 variants, 16 novel, including single nucleotide variants and exonic deletions. Detailed phenotypic analyses revealed that all subjects presented with a prominent forehead, hypertelorism, short nose, abnormality of the nasal tip, brachydactyly, mesomelic limb shortening, short stature, and genital hypoplasia in male patients. A total of 19 clinical features were present in more than 75% of the subjects, thus pointing to an overall uniformity of the phenotype. Disease-causing variants in ROR2, contribute to a clinically recognizable autosomal recessive trait phenotype with multiple skeletal defects. A comprehensive quantitative clinical evaluation of this cohort delineated the phenotypic spectrum of ROR2-related Robinow syndrome. The identification of exonic deletion variant alleles further supports the contention of a loss-of-function mechanism in the etiology of the syndrome.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  HPO terms; WNT pathway; chromosome microarray analysis; craniofacial morphology; exonic deletion; next-generation sequencing; quantitative phenotyping cluster heatmap; skeletal dysplasia

Mesh:

Substances:

Year:  2022        PMID: 35344616      PMCID: PMC9177636          DOI: 10.1002/humu.24375

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  45 in total

1.  Mutations in DVL1 cause an osteosclerotic form of Robinow syndrome.

Authors:  Kieran J Bunn; Phil Daniel; Heleen S Rösken; Adam C O'Neill; Sophia R Cameron-Christie; Tim Morgan; Han G Brunner; Angeline Lai; Henricus P M Kunst; David M Markie; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

Review 2.  Mechanisms underlying structural variant formation in genomic disorders.

Authors:  Claudia M B Carvalho; James R Lupski
Journal:  Nat Rev Genet       Date:  2016-02-29       Impact factor: 53.242

3.  A newly recognized dwarfing syndrome.

Authors:  M Robinow; F N Silverman; H D Smith
Journal:  Am J Dis Child       Date:  1969-06

4.  Characterization of the Robinow syndrome skeletal phenotype, bone micro-architecture, and genotype-phenotype correlations with the osteosclerotic form.

Authors:  Brian J Shayota; Chaofan Zhang; Roman J Shypailo; Juliana F Mazzeu; Claudia M B Carvalho; V Reid Sutton
Journal:  Am J Med Genet A       Date:  2020-09-05       Impact factor: 2.802

5.  Extremity anomalies associated with Robinow syndrome.

Authors:  Amjed Abu-Ghname; Jeffrey Trost; Matthew J Davis; V Reid Sutton; Chaofan Zhang; Diana E Guillen; Claudia M B Carvalho; Renata S Maricevich
Journal:  Am J Med Genet A       Date:  2020-09-25       Impact factor: 2.802

6.  Novel Robinow syndrome causing mutations in the proximal region of the frizzled-like domain of ROR2 are retained in the endoplasmic reticulum.

Authors:  Bassam R Ali; Steve Jeffery; Neha Patel; Lorna E Tinworth; Nagwa Meguid; Michael A Patton; Ali R Afzal
Journal:  Hum Genet       Date:  2007-07-31       Impact factor: 4.132

7.  Nonsense mutations in FZD2 cause autosomal-dominant omodysplasia: Robinow syndrome-like phenotypes.

Authors:  Keisuke Nagasaki; Gen Nishimura; Toru Kikuchi; Hiromi Nyuzuki; Sunao Sasaki; Yohei Ogawa; Akihiko Saitoh
Journal:  Am J Med Genet A       Date:  2018-01-31       Impact factor: 2.802

8.  WNT5A mutations in patients with autosomal dominant Robinow syndrome.

Authors:  Anthony D Person; Soraya Beiraghi; Christine M Sieben; Spencer Hermanson; Ann N Neumann; Mara E Robu; J Robert Schleiffarth; Charles J Billington; Hans van Bokhoven; Jeannette M Hoogeboom; Juliana F Mazzeu; Anna Petryk; Lisa A Schimmenti; Han G Brunner; Stephen C Ekker; Jamie L Lohr
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

9.  Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome.

Authors:  Chaofan Zhang; Juliana F Mazzeu; Jesper Eisfeldt; Christopher M Grochowski; Janson White; Zeynep C Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Anna Lindstrand; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  Am J Med Genet A       Date:  2020-10-13       Impact factor: 2.802

10.  Novel pathogenic variants and quantitative phenotypic analyses of Robinow syndrome: WNT signaling perturbation and phenotypic variability.

Authors:  Chaofan Zhang; Angad Jolly; Brian J Shayota; Juliana F Mazzeu; Haowei Du; Moez Dawood; Patricia Celestino Soper; Ariadne Ramalho de Lima; Bárbara Merfort Ferreira; Zeynep Coban-Akdemir; Janson White; Deborah Shears; Fraser Robert Thomson; Sarah Louise Douglas; Andrew Wainwright; Kathryn Bailey; Paul Wordsworth; Mike Oldridge; Tracy Lester; Alistair D Calder; Katja Dumic; Siddharth Banka; Dian Donnai; Shalini N Jhangiani; Lorraine Potocki; Wendy K Chung; Sara Mora; Hope Northrup; Myla Ashfaq; Jill A Rosenfeld; Kati Mason; Lynda C Pollack; Allyn McConkie-Rosell; Wei Kelly; Marie McDonald; Natalie S Hauser; Peter Leahy; Cynthia M Powell; Raquel Boy; Rachel Sayuri Honjo; Fernando Kok; Lucia R Martelli; Vicente Odone Filho; Donna M Muzny; Richard A Gibbs; Jennifer E Posey; Pengfei Liu; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  HGG Adv       Date:  2021-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.